Abstract
Uterine artery/fibroid embolization (UAE/UFE) is a minimally invasive treatment for symptomatic uterine fibroids and/or adenomyosis. The terms menorrhagia, metrorrhagia, and dysfunctional uterine bleeding have been abandoned by the International Federation of Gynaecology and Obstetrics (FIGO) due to confusion surrounding their use; in their place abnormal uterine bleeding (AUB) has been adopted. [1] Munro M.G. Critchley H.O.D. Fraser I.S. Committee tFMD. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynecol Obstet. 2018; 143: 393-408 Crossref PubMed Scopus (150) Google Scholar This is an overarching term to describe any symptomatic variation from normal menstruation incorporating prolonged menstrual bleeding (>8 days), heavy menstrual bleeding (HMB), and intermenstrual bleeding. Premenopausal AUB affects up to one third of women during their life and the risk of cancer in those who proceed to endometrial biopsy has been estimated at 0.33% (95% CI 0.23–0.48%), and 0.11% (95% CI 0.04–0.32) in the subset with HMB. [2] Pennant M.E. Mehta R. Moody P. et al. Premenopausal abnormal uterine bleeding and risk of endometrial cancer. BJOG. 2017 Feb; 124 ([PubMed PMID: 27766759. Pubmed Central PMCID: PMC5297977. Epub 2016/10/22. eng]): 404-411 Crossref PubMed Scopus (41) Google Scholar
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
